With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication for weight loss. "I'm on a GLP-1... this is the first time I've opened up ...

The use of weight loss drugs like Ozempic and Wegovy is growing in the Netherlands as more people opt to pay for ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view personal responsibility, government intervention and public health. One of the mor ...

The number of Netherlands residents using medicines like Ozempic, Wegovy, and Mounjaro for weight loss is increasing ...

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Exxon Mobil ...

It appears an unintended side effect of the drug has now struck some of Britain's known suitmakers, who are fed up with ...

Zealthy Weight Loss Overview Cost: $49 for your first month and $135 per month thereafter Types of weight loss medications: ...

Eli Lilly saw its shares close down 6.6% at $744.91 yesterday, after it revealed forecast for sales at the JP Morgan Healthcare Conference.

Why it matters: Lilly's growth prospects are driven by Mounjaro and Zepbound ... We also sell both admissions and sponsorship packages for our investment conferences and advertising on our ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...

"Sales of Mounjaro and Zepbound posted robust sales growth in Q4, and we expect a continuation of that trend into 2025. We'll also bring additional manufacturing capacity online and expect to produce ...